• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算研究依地普仑骨架对人去甲肾上腺素和 5-羟色胺转运体的选择性抑制作用。

Computational characterization of the selective inhibition of human norepinephrine and serotonin transporters by an escitalopram scaffold.

机构信息

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

出版信息

Phys Chem Chem Phys. 2018 Nov 28;20(46):29513-29527. doi: 10.1039/c8cp06232c.

DOI:10.1039/c8cp06232c
PMID:30457616
Abstract

Human norepinephrine and serotonin transporters (hNET and hSERT) are closely related monoamine transporters (MATs) that regulate neurotransmitter signaling in neurons and are primary targets for a wide range of therapeutic drugs used in the treatment of mood disorders. The subtle modifications of an escitalopram scaffold exhibit distinct selective inhibition profiles of hNET and hSERT. However, the structural details of escitalopram scaffold binding to hSERT and (or) hNET are poorly understood and still remain a great challenge. In this work, on the basis of more recently solved X-ray crystallographic structure of hSERT in complex with escitalopram, 3 μs long all-atom MD simulations and binding free energy calculations via MM/GB(PB)SA, thermodynamic integration (TI) and MM/3D-RISM methods were performed to reproduce experimental free energies. And both MM/GBSA and TI have a high correlation coefficient (R2 = 0.95 and 0.96, respectively) between the relative binding free energies of the calculated and experimental values. Furthermore, MM/GBSA per-residue energy decomposition, molecular interaction fingerprints and thermodynamics-structure relationship analysis were employed to investigate and characterize the selectivity of the escitalopram scaffold with three modifications (escitalopram, ligand10 and talopram) to hNET and hSERT. As a result, 4 warm spots (A73, Y151, A477 and I481) in hNET and 4 warm spots (A96, A173, T439 and L443) in hSERT were thus discovered to exert a pronounced effect on the selective inhibition of hNET and hSERT by the studied ligands. These simulation results would provide great insight into the design of inhibitors with the desired selectivity to hNET and hSERT, thus further promoting the research of more efficacious antidepressants.

摘要

人去甲肾上腺素和 5-羟色胺转运体(hNET 和 hSERT)是密切相关的单胺转运体(MATs),它们调节神经元中的神经递质信号传递,是广泛用于治疗情绪障碍的治疗药物的主要靶点。依地普仑骨架的细微修饰表现出对 hNET 和 hSERT 的独特选择性抑制特征。然而,依地普仑骨架与 hSERT 和(或)hNET 结合的结构细节知之甚少,仍然是一个巨大的挑战。在这项工作中,基于最近解决的 hSERT 与依地普仑复合物的 X 射线晶体结构,进行了 3 μs 长的全原子 MD 模拟和通过 MM/GB(PB)SA、热力学积分(TI)和 MM/3D-RISM 方法计算的结合自由能,以重现实验自由能。并且 MM/GBSA 和 TI 之间都具有计算值和实验值之间相对结合自由能的高相关系数(R2 分别为 0.95 和 0.96)。此外,采用 MM/GBSA 逐残基能量分解、分子相互作用指纹和热力学-结构关系分析,研究并表征了依地普仑骨架与三种修饰物(依地普仑、配体 10 和他普仑)对 hNET 和 hSERT 的选择性。结果,发现 hNET 中的 4 个热点(A73、Y151、A477 和 I481)和 hSERT 中的 4 个热点(A96、A173、T439 和 L443)对研究配体对 hNET 和 hSERT 的选择性抑制具有显著影响。这些模拟结果将为设计对 hNET 和 hSERT 具有所需选择性的抑制剂提供重要见解,从而进一步推动更有效的抗抑郁药的研究。

相似文献

1
Computational characterization of the selective inhibition of human norepinephrine and serotonin transporters by an escitalopram scaffold.计算研究依地普仑骨架对人去甲肾上腺素和 5-羟色胺转运体的选择性抑制作用。
Phys Chem Chem Phys. 2018 Nov 28;20(46):29513-29527. doi: 10.1039/c8cp06232c.
2
Understanding the Polypharmacological Profiles of Triple Reuptake Inhibitors by Molecular Simulation.通过分子模拟了解三重再摄取抑制剂的多药药理学特征。
ACS Chem Neurosci. 2021 Jun 2;12(11):2013-2026. doi: 10.1021/acschemneuro.1c00127. Epub 2021 May 12.
3
Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.用于治疗重度抑郁症的三重再摄取抑制剂阿米法丁结合机制的计算鉴定
Phys Chem Chem Phys. 2018 Feb 28;20(9):6606-6616. doi: 10.1039/c7cp07869b.
4
What Contributes to Serotonin-Norepinephrine Reuptake Inhibitors' Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics Simulation.是什么导致了 5-羟色胺-去甲肾上腺素再摄取抑制剂的双重作用机制?通过分子动力学模拟揭示了人类 5-羟色胺和去甲肾上腺素转运体跨膜结构域 6 的关键作用。
ACS Chem Neurosci. 2018 May 16;9(5):1128-1140. doi: 10.1021/acschemneuro.7b00490. Epub 2018 Jan 24.
5
An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.人血清素转运体上的一个变构结合位点介导了R-西酞普兰对艾司西酞普兰的抑制作用:对ALI/VFL-SI/TT突变体的动力学结合研究
Neurosci Lett. 2009 Oct 25;462(3):207-12. doi: 10.1016/j.neulet.2009.07.030. Epub 2009 Jul 16.
6
Comparative modeling of the human monoamine transporters: similarities in substrate binding.人类单胺转运体的比较建模:底物结合的相似性。
ACS Chem Neurosci. 2013 Feb 20;4(2):295-309. doi: 10.1021/cn300148r. Epub 2012 Nov 8.
7
Molecular dynamics simulations of Na+/Cl(-)-dependent neurotransmitter transporters in a membrane-aqueous system.膜水体系中Na⁺/Cl⁻依赖性神经递质转运体的分子动力学模拟
ChemMedChem. 2007 Jun;2(6):827-40. doi: 10.1002/cmdc.200600243.
8
Simultaneous Multiple MS Binding Assays for the Dopamine, Norepinephrine, and Serotonin Transporters.同时检测多巴胺、去甲肾上腺素和 5-羟色胺转运体的多重 MS 结合分析。
ChemMedChem. 2018 Mar 6;13(5):453-463. doi: 10.1002/cmdc.201700737. Epub 2018 Feb 16.
9
Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.抗抑郁药与 5-羟色胺和去甲肾上腺素转运体的相互作用:S1 底物结合口袋的突变研究。
J Biol Chem. 2012 Dec 21;287(52):43694-707. doi: 10.1074/jbc.M112.342212. Epub 2012 Oct 19.
10
Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.使用基因编码的光交联剂绘制艾司西酞普兰和帕罗西汀在人血清素转运体中的结合位点
ACS Chem Biol. 2017 Oct 20;12(10):2558-2562. doi: 10.1021/acschembio.7b00338. Epub 2017 Sep 26.

引用本文的文献

1
Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development.用于放射性示踪剂开发的先导化合物鉴定的计算化学
Pharmaceuticals (Basel). 2023 Feb 18;16(2):317. doi: 10.3390/ph16020317.
2
Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes.通过多种短分子动力学和自由能景观研究抑制剂对 CDK2 和 CDK6 的结合选择性依赖性分子机制。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):84-99. doi: 10.1080/14756366.2022.2135511.
3
Binding Selectivity of Inhibitors toward Bromodomains BAZ2A and BAZ2B Uncovered by Multiple Short Molecular Dynamics Simulations and MM-GBSA Calculations.
通过多次短分子动力学模拟和MM-GBSA计算揭示抑制剂对溴结构域BAZ2A和BAZ2B的结合选择性
ACS Omega. 2021 Apr 28;6(18):12036-12049. doi: 10.1021/acsomega.1c00687. eCollection 2021 May 11.
4
Profiling the structural determinants of aminoketone derivatives as hNET and hDAT reuptake inhibitors by field-based QSAR based on molecular docking.基于分子对接的场理论 QSAR 方法研究氨基酮衍生物作为 hNET 和 hDAT 重摄取抑制剂的结构决定因素。
Technol Health Care. 2021;29(S1):257-273. doi: 10.3233/THC-218024.
5
Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.负变构调节剂与 I 组代谢型谷氨酸受体结合的亚型选择性机制。
Acta Pharmacol Sin. 2021 Aug;42(8):1354-1367. doi: 10.1038/s41401-020-00541-z. Epub 2020 Oct 29.
6
Exploration of the selective binding mechanism of protein kinase Aurora A selectivity via a comprehensive molecular modeling study.通过全面的分子建模研究探索蛋白激酶Aurora A选择性的选择性结合机制。
PeerJ. 2019 Oct 22;7:e7832. doi: 10.7717/peerj.7832. eCollection 2019.
7
Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning.基于序列的深度学习同时提高稳定性、准确性和假阳性率的蛋白质功能注释。
Brief Bioinform. 2020 Jul 15;21(4):1437-1447. doi: 10.1093/bib/bbz081.
8
Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility.通过构建基于人工智能的增强可重复性方法,识别反映精神分裂症病因的基因特征。
CNS Neurosci Ther. 2019 Sep;25(9):1054-1063. doi: 10.1111/cns.13196. Epub 2019 Jul 27.
9
A structural model of the human serotonin transporter in an outward-occluded state.人血清素转运蛋白向外阻塞状态的结构模型。
PLoS One. 2019 Jun 28;14(6):e0217377. doi: 10.1371/journal.pone.0217377. eCollection 2019.
10
Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics.评估直接数据合并策略在长期和大规模药物代谢组学中的有效性。
Front Pharmacol. 2019 Feb 20;10:127. doi: 10.3389/fphar.2019.00127. eCollection 2019.